Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

kynostatin 272

Known as: 4-Thiazolidinecarboxamide, N-(1,1-dimethylethyl)-3- [2-hydroxy-3-[[2-[[(5-isoquinolinyloxy)acetyl]amino]-3- (methylthio)-1-oxopropyl]amino]-1-oxo-4-phenylbutyl]-,[4R-[3[2S*, 3S*(R*)],4R*]], KNI-272, kynostatin-272 
A synthetic peptide-based antiviral agent. As a peptidomimetic substrate containing an unnatural amino acid, allophenylnorstatine, KNI-272… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
We have created a simple algorithm for automatically predicting the explicit solvent atom distribution of biomolecules. The… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Amino acid substitutions in human immunodeficiency virus type 1 (HIV-1) Gag cleavage sites have been identified in HIV-1 isolated… Expand
Is this relevant?
2000
2000
KNI-272 is a powerful HIV-1 protease inhibitor with a reported inhibition constant in the picomolar range. In this paper, a… Expand
Is this relevant?
1999
1999
The aspartyl dyad of free HIV-1 protease has apparent pK(a)s of approximately 3 and approximately 6, but recent NMR studies… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The activity of three human immunodeficiency virus (HIV) protease inhibitors was investigated in human primary monocytes… Expand
Is this relevant?
1996
1996
In order to improve the design of HIV-1 protease inhibitors, it is essential to understand how they interact with active site… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Eleven different recombinant, drug-resistant HIV-1 protease (HIV PR) mutants--R8Q, V32I, M46I, V82A, V82F, V82I, I84V, V32I/I84V… Expand
Is this relevant?
1995
1995
BACKGROUND HIV-1 protease (HIV PR), an aspartic protease, cleaves Phe-Pro bonds in the Gag and Gag-Pol viral polyproteins… Expand
Is this relevant?
1994
1994
KNI-272 represents a peptide-based protease inhibitor having potent antiretroviral activity against human immunodeficiency virus… Expand
Is this relevant?
1992
1992
Selective and potent HIV protease inhibitors containing allophenylnorstatine [Apns; (2S, 3S)-3-amino-2-hydroxy-4-phenylbutyric… Expand
Is this relevant?